The global market for Microbial Fermentation Technology for Bio-Pharmaceutical Industries was estimated to be worth US$ 391680 million in 2023 and is forecast to a readjusted size of US$ 470740 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030

Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Microbial Fermentation Technology for Bio-Pharmaceutical Industries, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microbial Fermentation Technology for Bio-Pharmaceutical Industries by region & country, by Type, and by Application.

The Microbial Fermentation Technology for Bio-Pharmaceutical Industries market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Fermentation Technology for Bio-Pharmaceutical Industries.

Market Segmentation

Scope of Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market Report

Report Metric	Details
Report Name	Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market
Forecasted market size in 2030	US$ 470740 million
CAGR	2.7%
Forecasted years	2024 - 2030
Segment by Type:	Molds Algae Yeast Plant Cells Animal Cells Others
Segment by Application	Medicine Beauty and Health Products Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, DSM, Novozymes, Lonza, Corbion, N.V., Biocon, Kingdomway Group, Vtr Bio-Tech, Bloomage Biotechnology, Cathay Biotech Inc., BioVectra, Amyris, Vland Biotech, BrightGene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microbial Fermentation Technology for Bio-Pharmaceutical Industries manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Microbial Fermentation Technology for Bio-Pharmaceutical Industries in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Microbial Fermentation Technology for Bio-Pharmaceutical Industries in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market size in 2030?

Ans: The Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market size in 2030 will be US$ 470740 million.

Who are the main players in the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market report?

Ans: The main players in the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market are Roche, DSM, Novozymes, Lonza, Corbion, N.V., Biocon, Kingdomway Group, Vtr Bio-Tech, Bloomage Biotechnology, Cathay Biotech Inc., BioVectra, Amyris, Vland Biotech, BrightGene

What are the Application segmentation covered in the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market report?

Ans: The Applications covered in the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market report are Medicine, Beauty and Health Products, Others

What are the Type segmentation covered in the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market report?

Ans: The Types covered in the Microbial Fermentation Technology for Bio-Pharmaceutical Industries - Market report are Molds, Algae, Yeast, Plant Cells, Animal Cells, Others

1 Market Overview

1.1 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Product Introduction

1.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Size Forecast

1.3 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Trends & Drivers

1.3.1 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Industry Trends

1.3.2 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Drivers & Opportunity

1.3.3 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Challenges

1.3.4 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Players Revenue Ranking (2023)

2.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue by Company (2019-2024)

2.3 Key Companies Microbial Fermentation Technology for Bio-Pharmaceutical Industries Manufacturing Base Distribution and Headquarters

2.4 Key Companies Microbial Fermentation Technology for Bio-Pharmaceutical Industries Product Offered

2.5 Key Companies Time to Begin Mass Production of Microbial Fermentation Technology for Bio-Pharmaceutical Industries

2.6 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Competitive Analysis

2.6.1 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Fermentation Technology for Bio-Pharmaceutical Industries as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Molds

3.1.2 Algae

3.1.3 Yeast

3.1.4 Plant Cells

3.1.5 Animal Cells

3.1.6 Others

3.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type

3.2.1 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, by Type (2019-2030)

3.2.3 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medicine

4.1.2 Beauty and Health Products

4.1.3 Others

4.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application

4.2.1 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, by Application (2019-2030)

4.2.3 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region

5.1.1 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (2019-2024)

5.1.3 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (2025-2030)

5.1.4 Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

5.2.2 North America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

5.3.2 Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

5.4.2 Asia Pacific Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

5.5.2 South America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

5.6.2 Middle East & Africa Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value

6.3 United States

6.3.1 United States Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.3.2 United States Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.4.2 Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.5.2 China Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.5.3 China Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.6.2 Japan Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.7.2 South Korea Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.8.2 Southeast Asia Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019-2030

6.9.2 India Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

6.9.3 India Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Profile

7.1.2 Roche Main Business

7.1.3 Roche Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.1.4 Roche Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.1.5 Roche Recent Developments

7.2 DSM

7.2.1 DSM Profile

7.2.2 DSM Main Business

7.2.3 DSM Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.2.4 DSM Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.2.5 DSM Recent Developments

7.3 Novozymes

7.3.1 Novozymes Profile

7.3.2 Novozymes Main Business

7.3.3 Novozymes Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.3.4 Novozymes Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.3.5 Lonza Recent Developments

7.4 Lonza

7.4.1 Lonza Profile

7.4.2 Lonza Main Business

7.4.3 Lonza Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.4.4 Lonza Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.4.5 Lonza Recent Developments

7.5 Corbion, N.V.

7.5.1 Corbion, N.V. Profile

7.5.2 Corbion, N.V. Main Business

7.5.3 Corbion, N.V. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.5.4 Corbion, N.V. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.5.5 Corbion, N.V. Recent Developments

7.6 Biocon

7.6.1 Biocon Profile

7.6.2 Biocon Main Business

7.6.3 Biocon Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.6.4 Biocon Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.6.5 Biocon Recent Developments

7.7 Kingdomway Group

7.7.1 Kingdomway Group Profile

7.7.2 Kingdomway Group Main Business

7.7.3 Kingdomway Group Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.7.4 Kingdomway Group Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.7.5 Kingdomway Group Recent Developments

7.8 Vtr Bio-Tech

7.8.1 Vtr Bio-Tech Profile

7.8.2 Vtr Bio-Tech Main Business

7.8.3 Vtr Bio-Tech Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.8.4 Vtr Bio-Tech Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.8.5 Vtr Bio-Tech Recent Developments

7.9 Bloomage Biotechnology

7.9.1 Bloomage Biotechnology Profile

7.9.2 Bloomage Biotechnology Main Business

7.9.3 Bloomage Biotechnology Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.9.4 Bloomage Biotechnology Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.9.5 Bloomage Biotechnology Recent Developments

7.10 Cathay Biotech Inc.

7.10.1 Cathay Biotech Inc. Profile

7.10.2 Cathay Biotech Inc. Main Business

7.10.3 Cathay Biotech Inc. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.10.4 Cathay Biotech Inc. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.10.5 Cathay Biotech Inc. Recent Developments

7.11 BioVectra

7.11.1 BioVectra Profile

7.11.2 BioVectra Main Business

7.11.3 BioVectra Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.11.4 BioVectra Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.11.5 BioVectra Recent Developments

7.12 Amyris

7.12.1 Amyris Profile

7.12.2 Amyris Main Business

7.12.3 Amyris Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.12.4 Amyris Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.12.5 Amyris Recent Developments

7.13 Vland Biotech

7.13.1 Vland Biotech Profile

7.13.2 Vland Biotech Main Business

7.13.3 Vland Biotech Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.13.4 Vland Biotech Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.13.5 Vland Biotech Recent Developments

7.14 BrightGene

7.14.1 BrightGene Profile

7.14.2 BrightGene Main Business

7.14.3 BrightGene Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

7.14.4 BrightGene Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue (US$ Million) & (2019-2024)

7.14.5 BrightGene Recent Developments

8 Industry Chain Analysis

8.1 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Industrial Chain

8.2 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Model

8.5.2 Sales Channel

8.5.3 Microbial Fermentation Technology for Bio-Pharmaceutical Industries Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bloomage BioTechnology

List of Tables

Table 1. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Trends

Table 2. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Drivers & Opportunity

Table 3. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Challenges

Table 4. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Restraints

Table 5. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Microbial Fermentation Technology for Bio-Pharmaceutical Industries Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Microbial Fermentation Technology for Bio-Pharmaceutical Industries Product Type

Table 9. Key Companies Time to Begin Mass Production of Microbial Fermentation Technology for Bio-Pharmaceutical Industries

Table 10. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Fermentation Technology for Bio-Pharmaceutical Industries as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (2019-2024) & (%)

Table 27. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2025-2030) & (US$ Million)

Table 31. Roche Basic Information List

Table 32. Roche Description and Business Overview

Table 33. Roche Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 34. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Roche (2019-2024)

Table 35. Roche Recent Developments

Table 36. DSM Basic Information List

Table 37. DSM Description and Business Overview

Table 38. DSM Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 39. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of DSM (2019-2024)

Table 40. DSM Recent Developments

Table 41. Novozymes Basic Information List

Table 42. Novozymes Description and Business Overview

Table 43. Novozymes Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 44. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Novozymes (2019-2024)

Table 45. Novozymes Recent Developments

Table 46. Lonza Basic Information List

Table 47. Lonza Description and Business Overview

Table 48. Lonza Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 49. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Lonza (2019-2024)

Table 50. Lonza Recent Developments

Table 51. Corbion, N.V. Basic Information List

Table 52. Corbion, N.V. Description and Business Overview

Table 53. Corbion, N.V. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 54. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Corbion, N.V. (2019-2024)

Table 55. Corbion, N.V. Recent Developments

Table 56. Biocon Basic Information List

Table 57. Biocon Description and Business Overview

Table 58. Biocon Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 59. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Biocon (2019-2024)

Table 60. Biocon Recent Developments

Table 61. Kingdomway Group Basic Information List

Table 62. Kingdomway Group Description and Business Overview

Table 63. Kingdomway Group Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 64. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Kingdomway Group (2019-2024)

Table 65. Kingdomway Group Recent Developments

Table 66. Vtr Bio-Tech Basic Information List

Table 67. Vtr Bio-Tech Description and Business Overview

Table 68. Vtr Bio-Tech Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 69. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Vtr Bio-Tech (2019-2024)

Table 70. Vtr Bio-Tech Recent Developments

Table 71. Bloomage Biotechnology Basic Information List

Table 72. Bloomage Biotechnology Description and Business Overview

Table 73. Bloomage Biotechnology Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 74. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Bloomage Biotechnology (2019-2024)

Table 75. Bloomage Biotechnology Recent Developments

Table 76. Cathay Biotech Inc. Basic Information List

Table 77. Cathay Biotech Inc. Description and Business Overview

Table 78. Cathay Biotech Inc. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 79. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Cathay Biotech Inc. (2019-2024)

Table 80. Cathay Biotech Inc. Recent Developments

Table 81. BioVectra Basic Information List

Table 82. BioVectra Description and Business Overview

Table 83. BioVectra Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 84. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of BioVectra (2019-2024)

Table 85. BioVectra Recent Developments

Table 86. Amyris Basic Information List

Table 87. Amyris Description and Business Overview

Table 88. Amyris Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 89. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Amyris (2019-2024)

Table 90. Amyris Recent Developments

Table 91. Vland Biotech Basic Information List

Table 92. Vland Biotech Description and Business Overview

Table 93. Vland Biotech Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 94. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of Vland Biotech (2019-2024)

Table 95. Vland Biotech Recent Developments

Table 96. BrightGene Basic Information List

Table 97. BrightGene Description and Business Overview

Table 98. BrightGene Microbial Fermentation Technology for Bio-Pharmaceutical Industries Products, Services and Solutions

Table 99. Revenue (US$ Million) in Microbial Fermentation Technology for Bio-Pharmaceutical Industries Business of BrightGene (2019-2024)

Table 100. BrightGene Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Downstream Customers

Table 104. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Distributors List

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Product Picture

Figure 2. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (2019-2030) & (US$ Million)

Figure 4. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Report Years Considered

Figure 5. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Microbial Fermentation Technology for Bio-Pharmaceutical Industries Revenue in 2023

Figure 7. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Molds Picture

Figure 9. Algae Picture

Figure 10. Yeast Picture

Figure 11. Plant Cells Picture

Figure 12. Animal Cells Picture

Figure 13. Others Picture

Figure 14. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value Market Share by Type, 2023 & 2030

Figure 16. Product Picture of Medicine

Figure 17. Product Picture of Beauty and Health Products

Figure 18. Product Picture of Others

Figure 19. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (2019-2030) & (US$ Million)

Figure 22. North America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

Figure 27. South America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (2019-2030) & (US$ Million)

Figure 28. South America Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value (%), (2019-2030)

Figure 32. United States Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 34. United States Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 38. China Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 39. China Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 40. China Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 50. India Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value, (2019-2030) & (US$ Million)

Figure 51. India Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Type (%), 2023 VS 2030

Figure 52. India Microbial Fermentation Technology for Bio-Pharmaceutical Industries Sales Value by Application (%), 2023 VS 2030

Figure 53. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Industrial Chain

Figure 54. Microbial Fermentation Technology for Bio-Pharmaceutical Industries Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions